Oct 26, 2012
By Bob Komsic
Researchers found that among patients with the mutations, those who regularly took aspirin lived longer than those who didn’t.
About one-sixth of all colon cancer patients have the mutated gene and might be helped by aspirin.
The Harvard Medical School study is in this week’s New England Journal of Medicine.